About Us
Our Story
Team
Careers
News
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Select specialty
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Endocrinology
General Surgery
Hematology
Nephrology
Neurosurgery
Oncology
Oral Maxillofacial
Orthopaedics
Pediatrics
Plastic Surgery
Podiatry
Primary Care
Pulmonology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Confirm Password
The Future of CAR T Therapies in Myeloma in 2018
By
Nina Shah
3 Videos
06/2018
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
City of Hope
How the Experts Treat Hematologic Malignancies
Thu, Mar 21, 2019
Indy Hematology Review
16th Annual Indy Hematology Review
Sat, Mar 9, 2019
08:14
2018 Pan Pacific Lymphoma Conference
Evolution of Myeloma Induction Regimens
Feat.
S. Holstein
13:22
Parameswaran Hari
CAR T and NK Cell Therapy in Myeloma
15:46
Society of Hematologic Oncology Sixth Annual Meeting
Myeloma State of the Art Update: Bone Disease, MRD Assessment, How to Ma...
Feat.
S. Lonial
09:49
Nina Shah
Maximizing the Initial Gains in Myeloma Therapy: Consolidation and Maint...
15:01
Krina Patel
Clinical Trials in Myeloma in 2018
10:29
Society of Hematologic Oncology Sixth Annual Meeting
Next Questions in Myeloma: Biology, Smoldering Myeloma, High-risk, MRD, ...
Feat.
S. Jagannath
19:40
Peter Voorhees
Approach to the Patient with Refractory & Multiple Relapsed Multiple Mye...
12:31
Indy Hematology Review
What's New in Immunotherapy and Genomics in Multiple Myeloma?
Feat.
K. Anderson
15:10
Ajay Nooka
Early Relapse: Choosing Among Different Second Line Regimens in Myeloma
15:30
Parameswaran Hari
Refractory and Relapsing Myeloma - When to Treat and Options Available
09:45
2018 Pan Pacific Lymphoma Conference
CAR T-cell Toxicities and Team Managment
Feat.
S. Blumel
13:29
Helen Heslop
CAR T-cell Therapy for Hematologic Malignancies Other Than CD19
10:37
Krina Patel
How Do We Make Responses Durable in Multiple Myeloma?
17:46
Dana-Farber Cancer Institute
Relapse Refractory Myeloma and Novel Treatments
Feat.
N. Raje
06:22
Parameswaran Hari
Treating Refractory & Relapsing Myeloma: Current Trends and Recommendati...
09:00
Maria-Victoria Mateos
FDA Approves Once-Weekly Carfilzomib Regimen for Myeloma
14:42
Society of Hematologic Oncology Sixth Annual Meeting
What Will The Future Hold for Myeloma Treatment CARTs vs BiTES?
Feat.
R. Orlowski
11:50
C. Ola Landgren
Aiming for Minimal Residual Disease Negative Status in all Myeloma Patients
15:44
Society of Hematologic Oncology Sixth Annual Meeting
The Role of ASCT In The Era of Modern MM Therapy
Feat.
P. Voorhees
03:33
Krina Patel
The Future in Multiple Myeloma: BiTE, CAR T, PI, & IMID